Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1992 Jul;12(4):266-70.
doi: 10.1007/BF00918150.

Chronic enteroviral meningoencephalitis in agammaglobulinemia: case report and literature review

S A Misbah  1 , G P Spickett, P C Ryba, J M Hockaday, J S Kroll, C Sherwood, J B Kurtz, E R Moxon, H M Chapel
Affiliations
Review

Chronic enteroviral meningoencephalitis in agammaglobulinemia: case report and literature review

S A Misbah et al. J Clin Immunol. 1992 Jul.

Abstract

Chronic enteroviral meningoencephalitis is a well-recognized complication in patients with X-linked agammaglobulinemia (XLA). The majority of published cases refers to its occurrence in patients on no replacement therapy or on only intramuscular immunoglobulin. The advent of intravenous immunoglobulin (IVIg) in the early 1980s and its widespread use in XLA was thought to have virtually eradicated enteroviral meningoencephalitis in these patients. We describe the development of echovirus meningoencephalitis in an 11-year-old boy on regular IVIg replacement whose serum IgG levels were maintained at between 6 and 8 g/L (NR 6-13 g/L). Treatment with daily high-dose IVIg was commenced, with significant clinical improvement being noted within a few weeks in association with a reduction in blood-brain barrier permeability. The persistence of live virus, however, necessitated the use of intraventricular immunoglobulin. The virus proved resistant to two courses of specific intraventricular immunoglobulin and a 6-week course of oral ribavirin and eventually proved fatal 5 months after presentation. In view of the therapeutic uncertainties we have reviewed the use of immunoglobulin in the treatment of enteroviral meningoencephalitis over the past 6 years.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Aust N Z J Med. 1985 Aug;15(4):443-5 - PubMed
    1. N Engl J Med. 1985 Sep 19;313(12):758 - PubMed
    1. N Engl J Med. 1985 Dec 12;313(24):1546-7 - PubMed
    1. Pediatr Infect Dis J. 1988 May;7(5 Suppl):S30-3 - PubMed
    1. N Engl J Med. 1981 May 21;304(21):1278-81 - PubMed

MeSH terms

LinkOut - more resources